BioSpace News Archive

CollaborateMD, a leading provider of cloud-based medical billing and practice management solutions, has been selected by Modern Healthcare as one of the 2019 Best Places to Work in Healthcare.

ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full service CRO, and technology-led life sciences service provider, chose ThoughtSphere to power OneClinical Analytics, which is an intelligent digital, clinical analytics platform.

A non-steroidal, non-opioidal investigational study medication, already approved for use in Japan [Hernicore®], for those with sciatica or leg pain from a herniated lumbar disc is now being evaluated in a clinical research study in the United States, The Discovery 6603 Study.

- FDA removed the partial clinical hold based upon agreement on revisions to the CANOVA study protocol, including new risk mitigation measures, protocol-specified guidelines and updated futility criteria

Obesity is One of the Largest Drivers of Preventable Chronic Disease; LeanMD’s 360 Degree Solution is Medically Supervised, Pharmaceutically Enhanced, and Features Advancements in Healthcare

Despite our advances in health care over the last century, millions now face new risks, including unaffordable costs and unsuitable health infrastructure

Rinovum Women’s Health, the makers of the successful Stork® products for at-home conception has debuted a breakthrough reusable device, clinically proven to treat light bladder leaks that does not require a prescription, impacting the more than 15 million women in the U.S. who suffer from the embarrassing issue.

At an event today at The White House, physicians from the Docs4PatientCare Foundation (D4PCF), the only health care organization composed of practicing physicians with hands-on, practical knowledge of the American health care system joined President Trump as he signed an Executive Order demanding transparency in what has become an opaque cost/pricing system.

Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), priced a private offering (the “Private Offering”) of $500.0 million in aggregate principal amount of 5.00% senior unsecured notes due 2027 (the “Notes”) at par.

Maetrics, a leading international life sciences regulatory and compliance consultancy, has launched a new whitepaper on the adaptations and additions to the EU Medical Device Regulation (MDR) pertaining to drug device combination products.